Drugs of seven pharma firms declared ‘spurious’

Published
0

ISLAMABAD: The Drug Testing Laboratory (DTL) has identified drugs of as many as seven pharmaceutical companies as spurious. It has claimed that some drugs may contain toxic and narcotic/psychotropic ingredients in unacceptable doses which may be life threatening.

Medicines were being sold in the market but the licence numbers on the products were never allotted to those products. Even addresses of the pharmaceutical companies, mentioned on the drugs, were fake.

According to documents signed by the DTL Sindh director, Syed Adnan Rizvi, and seen by Dawn, the lab performed testing of drugs taken by various provincial drug inspectors and products of seven pharmaceutical companies were found to be fictitious, having no existence, possessing fake manufacturing licence and registration number, and devoid of Active Pharma­ceutical Ingredients (API) hence declared as spurious.

The medicines include Eyosef 250mg capsules (used to treat infections caused by bacteria, including upper respiratory infections, ear infections, skin infections and urinary tract infections) manufactured by M/S East Pharmaceuticals, Lahore.

Drug Testing Lab warns these medicines may contain toxic ingredients that may be ‘life threatening’

As many as three suspensions [used to treat bacterial infections in many different parts of the body] including Alcoxime suspension, manufactured by M/S Alpine Laboratories (Pvt) Ltd, Karachi; Milixime suspension, manufactured by M/S Menakline Pharma, Karachi; and Mirzpan suspension,

manufactured by M/S Miraz Pharma, Kasur, were also found spurious. M/S Miraz Pharma’s product Mirzolam tablets

(used to treat anxiety disorders, panic disorders, and anxiety caused by depression) was also found spurious.

Documents reveal that M/S Porm Pharmaceuticals, Pesha­war’s Lexopam tablets [used to treat panic disorders and severe anxiety], M/S Multicare Pharmaceutical Karachi’s product Zionex tablet (used to treat panic disorders and anxiety) and M/S Brom Pharmaceuticals Lahore’s medicine Bromalex (used to treat panic disorders and severe anxiety) were also found spurious.

Risk statements

Documents shared with health facilities, health authorities and pharma manufacturers associations say that consequences of use of spurious/falsified drugs may be severe as those drugs may contain toxic and narcotic/psychotropic ingredients in unacceptable doses, which may be life threatening.

They are manufactured under unhygienic conditions without the proper inspection and approval and they are highly injurious to human health. Poor quality medicines compromise the treatment of diseases and may intensify the existing conditions, the documents say.

President of Pakistan Drug Lawyers Forum, Noor Mahar, while talking to Dawn, said that the medicines were being sold in the market, but the licence numbers of these products were never allotted.

Even addresses of the pharmaceutical companies mentioned on the drugs were fake, he said.

Published in Dawn, February 18th, 2025

Opinion

Editorial

Kashmir unresolved
Updated 30 Sep, 2026

Kashmir unresolved

The just solution lies in India addressing the issue through a trilateral dialogue involving the legitimate representatives of the Kashmiri people and Pakistan.
Water shortage
30 Sep, 2026

Water shortage

THAT the country is entering the Rabi season with an anticipated water shortage of nearly 25pc, the lowest carryover...
Young hearts
30 Sep, 2026

Young hearts

THE observance may have passed, but the message of World Heart Day should not fade with it. The occasion is a useful...
Terror and politics
Updated 29 Sep, 2026

Terror and politics

There is an urgent need to tone down the rhetoric and tackle terrorism as a collective challenge for both the affected provinces and the federation.
Watching the glaciers
29 Sep, 2026

Watching the glaciers

THE latest signs from Pakistan’s mountains are worrying. Suparco says the number of unfrozen glacial lakes it...
Dangerous agenda
29 Sep, 2026

Dangerous agenda

AS the world remains fixated on the US-Iran conflict, elsewhere in the Middle East, Israel is consolidating its grip...